Glyxambi 5 mg/1 (Empagliflozin and Linagliptin TABLET, FILM COATED) 5 mg/1

Glyxambi 5 mg/1 combines empagliflozin and linagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

Strength

5 mg/1

Pack Size

90 TABLET, FILM COATED in 1 BOTTLE (0597-0164-90)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glyxambi 5 mg/1 is used to help manage type 2 diabetes in adults. It works by combining two active ingredients, empagliflozin and linagliptin, to support blood sugar regulation. This medication is often prescribed alongside diet and exercise to improve glycemic control. People may ask, 'What is Glyxambi used for?' and the answer is that it is designed to assist in maintaining healthy blood sugar levels.

Side Effects

Common effects of Glyxambi 5 mg/1 may include urinary tract infections, hypoglycemia, and upper respiratory tract infections. Some individuals might experience dizziness or headache. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Glyxambi 5 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is essential to follow the prescribed dosage and storage instructions. Always inform your healthcare provider about any existing medical conditions before starting this medication.

Avoid Interactions

Glyxambi 5 mg/1 may interact with certain medications, including other diabetes treatments, diuretics, and drugs that affect kidney function. Alcohol and certain supplements might also influence its effectiveness. Always discuss potential interactions with a healthcare professional.

Frequently Asked Questions

Glyxambi 5 mg/1 is used to help manage type 2 diabetes by supporting blood sugar control.

Glyxambi 5 mg/1 should be stored at room temperature, away from moisture and heat.

Common side effects may include urinary tract infections, hypoglycemia, and upper respiratory tract infections.

Glyxambi 5 mg/1 may interact with other medications, so it's important to consult a healthcare provider before combining it with other treatments.

Glyxambi 5 mg/1 is not suitable for everyone, especially those with certain kidney conditions or a history of pancreatitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.